Table 1.

Diagnosis Categories Among Patients Transplanted for Restrictive Heart Disease by era (Transplants: January 1992-June 2018)

	January 1992-December 2000 (n = 760)	January 2001-December 2009 (n = 1417)	January 2010-June 2018 (n = 2129)	p-value
Hypertrophic cardiomyopathy	352 (46.3%)	752 (53.1%)	1065 (50.0%)	<0.0001
Amyloid	53 (7.0%)	114 (8.0%)	299 (14.0%)
Sarcoid	25 (3.3%)	50 (3.5%)	133 (6.2%)
Radiation/chemotherapy	9 (1.2%)	26 (1.8%)	53 (2.5%)
Other restrictive cardiomyopathy	321 (42.2%)	475 (33.5%)	579 (27.2%)
– Idiopathic	203 (26.7%)	240 (16.9%)	266 (12.5%)
– Endocardial Fibrosis	9 (1.2%)	12 (0.8%)	16 (0.8%)
– Other	109 (14.3%)	223 (15.7%)	297 (14.0%)

Continuous factors are expressed as median (5th−95th percentiles).

Summary statistics included transplants with non-missing data.

Diagnosis categories (with “Other RCM” combined) were compared using the chi-square statistic using single p-value.